Le Lézard
Classified in: Health
Subject: SCZ

Governor Sununu Selects Benchmark at Rye Mind & Memory Care Director for Alzheimer's Subcommittee


Meghan Wentworth, CDP, to Lend Her Years of Memory Care Assisted Living Expertise to Help Implement Statewide Policies Amid Growing Crisis

RYE, N.H., April 7, 2023 /PRNewswire-PRWeb/ -- Benchmark Senior Living, the largest senior housing provider in New England, today announced that Meghan Wentworth, CDP, of Barrington, the Mind & Memory Care Director for Benchmark at Rye, has been selected by New Hampshire Governor Chris Sununu to serve on the state's Alzheimer's and Related Dementia subcommittee. Wentworth will represent the assisted living industry as the subcommittee's sole assisted living representative.

Established in 2014, the subcommittee oversees Alzheimer's in the state, including developing educational programs and training as it advocates for the more than 26,000 individuals and the 58,000 caregivers in New Hampshire effected by dementia. It includes representatives from care providers, state agencies, law enforcement, state legislators, caregivers and other individuals impacted by Alzheimer's.

"I am incredibly honored to be able to serve New Hampshire families in this way," said Wentworth. "There is still so much that needs to be done to support the growing number of families facing a dementia diagnosis and I'm thrilled to be able to share my experience."

Wentworth is a Certified Dementia Practitioner (CDP) and has nearly 15 years of assisted living with memory care experience. Before joining Benchmark in January, she served as the memory support manager for RiverWoods in Durham.

In her free time, she serves as the event chair for the Seacoast Walk to End Alzheimer's, a position she has held for over three years and as an advocate for the Alzheimer's Association, Massachusetts/New Hampshire chapter. She has also served as the New Hampshire State Lead for Dementia Friendly America.

"We feel very fortunate to have her passion representing our community and our state as we all work together to end Alzheimer's," said Rob Memmolo, executive director of Benchmark at Rye.

# # #

About Benchmark Senior Living
Benchmark is New England's largest senior living provider with 65 independent living, assisted living, memory care and continuing care communities and over 5,000 dedicated associates providing compassionate care and outstanding experiences throughout the Northeast. The Waltham, Mass.-based company was founded over 25 years ago by Tom Grape with the purpose of Transforming Lives Through Human Connection. Since then, Benchmark has continued to set the industry standard, having won over a hundred local, regional and national awards for its care, programs and as a top workplace. Benchmark has been named one of the Top Places to Work for 15 straight years in The Boston Globe's annual employee-based survey and received repeated recognition in FORTUNE's Best Workplaces for Aging Services list. For more information, visit BenchmarkSeniorLiving.com.

Media Contact

Carol Arnold, Benchmark Senior Living, 6035020469, [email protected]

 

SOURCE Benchmark Senior Living


These press releases may also interest you

at 06:50
Pfizer Inc. highlights its progress in advancing new potential standards of care in Oncology at the 2024 American Society of Clinical Oncology (ASCO®) Annual Meeting, taking place May 31 to June 4 in Chicago. More than 50 abstracts, including 11...

at 06:30
Leica Biosystems is pleased to announce that its flagship digital pathology system, Aperio GT 450 DX, has received 510(k) clearance from the US Food and Drug Administration. Previously sold into the clinical market under an enforcement discretion due...

at 06:17
Local Infusion, a technology-driven provider for patients with chronic autoimmune diseases on specialty infusion therapy, announced the opening of a state-of-the-art infusion center in New Haven, Connecticut. We are excited about our continued...

at 06:05
Revvity, Inc. , today reported financial results for the first quarter ended March 31, 2024. The Company reported GAAP earnings per share of $0.21, as compared to $4.50 in the same period a year ago. GAAP revenue for the quarter was $650 million,...

at 06:00
Theravance Biopharma, Inc. will report its first quarter 2024 financial results and provide a business update after market close on Monday, May 13, 2024. An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm ET (2:00 pm...

at 06:00
Repertoire® Immune...



News published on and distributed by: